All the results suggested that further silencing SOX6 expression in Kyse30-miR-208-inhibitor and Kyse410-miR-208-inhibitor cells could reverse the inhibitory effect of the miR-208 inhibitor on ESCC cells proliferation. The gene discussed is SOX6; the disease is esophageal squamous cell carcinoma.